ID   ARPE-19/EGFP
AC   CVCL_IQ61
SY   ARPE/GFP; P-393-1; NTC200p393(1)
DR   Wikidata; Q54750560
RX   Patent=US6361771;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2522.
CC   Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0145 ! ARPE-19
SX   Male
AG   19Y
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 9
//
RX   Patent=US6361771;
RA   Tao W., Rein D.H., Dean B.J., Stabila P.F., Goddard M.B.I.;
RT   "ARPE-19 as a platform cell line for encapsulated cell-based
RT   delivery.";
RL   Patent number US6361771, 26-Mar-2002.
//